Literature DB >> 20155401

A simple risk score to predict in-hospital mortality after pancreatic resection for cancer.

Joshua S Hill1, Zheng Zhou, Jessica P Simons, Sing Chau Ng, Theodore P McDade, Giles F Whalen, Jennifer F Tseng.   

Abstract

BACKGROUND: Pancreatectomy for cancer continues to have substantial perioperative risk, and the factors affecting mortality are ill defined. An integer-based risk score based on national data might help clarify the risk of in-hospital mortality in patients undergoing pancreatic resection.
METHODS: Records with the diagnosis of pancreatic cancer were queried from the Nationwide Inpatient Sample for 1998-2006. Procedures were categorized as proximal, distal, or nonspecified pancreatectomies on the basis of ICD-9 codes. Logistic regression and bootstrap methods were used to create an integer risk score for estimating the risk of in-hospital mortality using patient demographics, comorbidities (Charlson comorbidity score), procedure, and hospital type. A random sample of 80% of the cohort was used to create the risk score with a 20% internal validation set.
RESULTS: A total of 5715 patient discharges were identified. Composite in-hospital mortality was 5.8%. Predictors used for the final model were age group, Charlson score, sex, type of pancreatectomy, and hospital volume status (low-, medium-, or high-volume center). Integer values were assigned to these characteristics and then used for calculating an additive score. Three clinically useful score groups were defined to stratify the risk of in-hospital mortality (mortality was 2.0, 6.2, and 13.9%, respectively; P < 0.0001), with a 6.95-fold difference between the low- and high-risk groups. There was sufficient discrimination of both the derivation set and the validation set, with c statistics of 0.71 and 0.72, respectively.
CONCLUSIONS: An integer-based risk score can be used to accurately predict in-hospital mortality after pancreatectomy and may be useful for preoperative risk stratification and patient counseling.

Entities:  

Mesh:

Year:  2010        PMID: 20155401     DOI: 10.1245/s10434-010-0947-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  32 in total

1.  Risk of morbidity and mortality following hepato-pancreato-biliary surgery.

Authors:  Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2012-07-04       Impact factor: 3.452

2.  Pancreatectomy risk calculator: an ACS-NSQIP resource.

Authors:  Purvi Parikh; Mira Shiloach; Mark E Cohen; Karl Y Bilimoria; Clifford Y Ko; Bruce L Hall; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

3.  Comparison of observed to predicted outcomes using the ACS NSQIP risk calculator in patients undergoing pancreaticoduodenectomy.

Authors:  Harveshp D Mogal; Nora Fino; Clancy Clark; Perry Shen
Journal:  J Surg Oncol       Date:  2016-05-04       Impact factor: 3.454

4.  A root-cause analysis of mortality following major pancreatectomy.

Authors:  Charles Mahlon Vollmer; Norberto Sanchez; Stephen Gondek; John McAuliffe; Tara S Kent; John D Christein; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

5.  External assessment of the Early Mortality Risk Score in patients with adenocarcinoma undergoing pancreaticoduodenectomy.

Authors:  Gaëtan-Romain Joliat; David Petermann; Nicolas Demartines; Markus Schäfer
Journal:  HPB (Oxford)       Date:  2015-04-23       Impact factor: 3.647

6.  Novel diagnostics for aggravating pancreatic fistulas at the acute phase after pancreatectomy.

Authors:  Mitsuro Kanda; Tsutomu Fujii; Hideki Takami; Masaya Suenaga; Yoshikuni Inokawa; Suguru Yamada; Daisuke Kobayashi; Chie Tanaka; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

7.  Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group.

Authors:  Apeksha Dave; Eliza W Beal; Alexandra G Lopez-Aguiar; George Poultsides; Eleftherios Makris; Flavio G Rocha; Zaheer Kanji; Sean Ronnekleiv-Kelly; Victoria R Rendell; Ryan C Fields; Bradley A Krasnick; Kamran Idrees; Paula Marincola Smith; Hari Nathan; Megan Beems; Shishir K Maithel; Timothy M Pawlik; Carl R Schmidt; Mary E Dillhoff
Journal:  J Gastrointest Surg       Date:  2019-04-02       Impact factor: 3.452

8.  Volume-outcome relationships in pancreatoduodenectomy for cancer.

Authors:  Lydia G M van der Geest; L Bengt van Rijssen; I Quintus Molenaar; Ignace H de Hingh; Bas Groot Koerkamp; Olivier R C Busch; Valery E P P Lemmens; Marc G H Besselink
Journal:  HPB (Oxford)       Date:  2016-02-11       Impact factor: 3.647

9.  Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.

Authors:  Raphael L C Araujo; Sébastien Gaujoux; Florence Huguet; Mithat Gonen; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; T Peter Kingham; William R Jarnagin; Karyn A Goodman; Peter J Allen
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

10.  Computed tomography attenuation and patient characteristics as predictors of complications after pancreaticoduodenectomy.

Authors:  John C McAuliffe; Karen Parks; Prakash Kumar; Sandre F McNeal; Desiree E Morgan; John D Christein
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.